CALC
CALCIMEDICA (CALC)
NASDAQ
$0.84+$0.04 (+5.06%)
Price as of Jun 03, 2026 7:14 PM EDT
  • $12.9M
    Market Cap
  • -50.89%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
713,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
713,000
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-15.2M
+5.22%
-14.5M
-8.71%
-15.9M
+12.37%
-14.1M
-25.34%
Depreciation and Amortization Expense
46,000
-20.69%
58,000
0.00%
58,000
-82.84%
338,000
-34.87%
Total Operating Expenses
23.1M
-4.47%
24.2M
-36.43%
38.1M
+5.24%
36.2M
+0.65%
Operating Profit
-23.1M
-4.47%
-24.2M
-36.43%
-38.1M
+5.24%
-36.2M
+0.65%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
575,000
+356.35%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
-100.00%
575,000
+356.35%
Total Nonoperating Income and Expense
-6.4M
-161.32%
10.5M
+182.52%
3.7M
N/A
N/A
N/A
Income before Taxes
-23.1M
-4.47%
-24.2M
-29.55%
-34.4M
-5.04%
-36.2M
+1.00%
Income Taxes
0
N/A
0
-100.00%
1,000
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
1.6M
N/A
Net Income
-29.6M
+115.78%
-13.7M
-60.12%
-34.4M
-3.51%
-35.6M
-0.60%
Net Income from Continuing Operations Applicable to Common
-29.6M
+115.78%
-13.7M
-60.12%
-34.4M
-3.51%
-35.6M
-0.60%
Basic EPS and Net Income
-1.97
+61.48%
-1.22
-84.07%
-7.66
+361.45%
-1.66
-1.78%
Diluted EPS and Net Income
-1.97
+61.48%
-1.22
-84.07%
-7.66
+361.45%
-1.66
-1.78%
Basic Weighted Average Shares
15.0M
+33.48%
11.2M
+150.67%
4.5M
-79.12%
21.5M
+1.37%
Diluted Weighted Average Shares
15.0M
+33.48%
11.2M
+150.67%
4.5M
-79.12%
21.5M
+1.37%
Balance Sheet
Cash and Cash Equivalents
11.5M
+45.18%
7.9M
+43.49%
5.5M
-68.04%
17.3M
+29.48%
Short-Term Investments
1.5M
-86.06%
10.7M
+88.05%
5.7M
-73.85%
21.8M
-56.62%
Cash and Cash Equivalents and Short-Term Investments
13.0M
-30.28%
18.7M
+66.12%
11.2M
-71.28%
39.1M
-38.55%
Total Current Assets
13.5M
-31.20%
19.7M
+69.45%
11.6M
-70.75%
39.7M
-40.86%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
1.7M
0.00%
Property and Plant and Equipment and Net
50,000
-57.98%
119,000
-28.74%
167,000
-91.57%
2.0M
0.00%
Total Long-Term Assets
11,000
+10.00%
10,000
-97.58%
413,000
-79.15%
2.0M
0.00%
Total Assets
13.6M
-31.34%
19.8M
+62.45%
12.2M
-69.28%
39.7M
-42.58%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
3.8M
+2.66%
3.7M
-8.54%
4.0M
+8.89%
3.7M
-8.82%
Total Long-Term Debt
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Total Long-Term Liabilities
8.0M
+370.59%
1.7M
N/A
0
-100.00%
8,000
0.00%
Total Liabilities
20.2M
+275.78%
5.4M
+33.66%
4.0M
+8.89%
3.7M
-9.00%
Retained Earnings
-189.3M
+18.50%
-159.8M
+9.38%
-146.1M
-28.68%
-204.8M
+21.04%
Total Stockholders Equity
-6.6M
-146.09%
14.4M
+76.66%
8.2M
-77.32%
36.0M
-44.68%
Total Shares Outstanding
15.4M
+14.50%
13.5M
+134.28%
5.8M
-73.48%
21.7M
+1.59%
Cash Flow
Cash from Operating Activities
-21.2M
+0.15%
-21.1M
-17.82%
-25.7M
+12.46%
-22.9M
-27.37%
Capital Expenditures
28,000
+250.00%
8,000
-89.74%
78,000
-74.68%
308,000
-36.89%
Cash from Investing Activities
9.6M
+315.94%
-4.4M
-149.79%
8.9M
-67.05%
27.0M
+150.75%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
15.2M
-45.62%
28.0M
+33.85%
20.9M
+15,135.97%
-139,000
-120.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-3,242.78%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-177.10%
+106.69%
-85.68%
-35.34%
-132.51%
+102.38%
-65.48%
+56.17%
Return on Equity
-761.02%
+526.79%
-121.42%
-22.03%
-155.72%
+120.84%
-70.51%
+57.28%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.58
-32.98%
5.34
+85.27%
2.88
-73.14%
10.72
-35.14%
Cash Ratio
3.05
+41.42%
2.15
+56.89%
1.37
-70.65%
4.68
+42.01%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow